(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate

(2E, 4E, 6Z, 8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-l-yl) nona-2,4,6,8-tetraen-l-yl acetate
Trade Name
Orphan Indication Retinitis pigmentosa
USA Market Approval USA
USA Designation Date 2010-12-02 00:00:00
Sponsor Novelion Therapeutics, Inc.;887 Great Northern Way - Suite 250, Vancouver, British Columbia, V5T 4T5;